ebola
viru
ebov
highli
pathogen
filoviru
caus
hemorrhag
fever
human
anim
current
ebov
fuse
envelop
membran
within
endosom
membran
caus
infect
poorli
understood
success
measur
cellcel
fusion
mediat
ebov
fusion
protein
gp
assay
transfer
cytoplasm
membran
dye
small
molecul
fusion
inhibitor
neutral
antibodi
well
mutat
ebov
gp
known
reduc
viral
infect
greatli
reduc
fusion
monitor
redistribut
small
aqueou
dye
cell
electr
capacit
measur
discov
ebov
gpmediat
fusion
pore
readili
enlarg
mark
differ
behavior
viral
fusion
protein
ebov
gp
must
cleav
late
endosomeresid
cathepsin
b
l
order
becom
fusioncompet
cleavag
cell
surfaceexpress
gp
appear
occur
endosom
evidenc
fusion
block
impos
cathepsin
inhibitor
agent
rais
endosom
ph
inhibitor
anterograd
traffick
treat
effector
cell
recombin
solubl
cathepsin
b
thermolysin
cleav
gp
activ
form
increas
extent
fusion
suggest
fraction
surfaceexpress
gp
cleav
wherea
rate
fusion
increas
brief
exposur
acid
ph
fusion
occur
neutral
ph
importantli
extent
fusion
independ
extern
ph
experi
cathepsin
activ
block
ebov
gp
cleav
thermolysin
result
impli
low
ph
promot
fusion
wellknown
phdepend
activ
cathepsin
fusion
induc
cleav
ebov
gp
process
fundament
independ
ph
cellcel
fusion
system
reveal
previous
unappreci
featur
ebov
entri
could
readili
elucid
context
endosom
entri
devast
transmiss
ebola
viru
ebov
well
known
howev
manner
ebov
enter
host
cell
endosom
membran
remain
elus
develop
conveni
experiment
system
mimic
ebov
fusion
endosom
cell
express
fusion
protein
ebov
gp
surfac
fuse
target
cell
system
exhibit
known
key
properti
ebov
fusion
show
phdepend
ebov
fusion
caus
phdepend
cathepsin
proteas
known
cleav
ebov
gp
fusioncompet
form
demonstr
fusion
activ
cleav
form
independ
ph
show
enlarg
fusion
pore
creat
ebov
gp
unusu
slow
reach
size
necessari
pass
ebov
genomethi
atyp
viral
creat
fusion
pore
cellcel
fusion
system
provid
use
platform
develop
drug
ebov
infect
util
fluoresc
dye
spread
assay
monitor
cellcel
fusion
effector
cell
transfect
express
ebov
gp
load
calceinam
caam
green
pretreat
thermolysin
th
shown
thermolysin
treatment
cleav
viral
membran
fusioncompet
kda
subunit
within
laboratori
thermolysin
therefor
often
use
lieu
membranebound
cathepsin
cleav
subunit
fusioncompet
form
cell
bound
target
cell
either
unlabel
purpos
microscop
identif
load
aqueou
dye
cmac
blue
lower
extern
ph
min
room
temperatur
reneutr
rais
temperatur
monitor
dye
spread
variou
time
track
transfer
calcein
cell
quantifi
extent
fusion
cmac
use
sole
identifi
target
cell
fraction
cell
stain
calcein
cmac
hr
low
ph
puls
compar
cellcel
fusion
mediat
ebov
gp
jaagsiekt
sheep
retroviru
jsrv
env
influenza
viru
iav
hemagglutinin
ha
requir
low
ph
fusion
proceed
fig
fusion
occur
effector
cell
mock
transfect
establish
caam
transfer
due
fusion
top
row
often
thought
ebov
fusion
requir
acid
ph
found
thermolysintr
effector
cell
express
ebov
gp
also
fuse
target
cell
neutral
ph
fig
bar
albeit
smaller
extent
occur
hr
min
exposur
acid
ph
room
temperatur
bar
repres
imag
dye
transfer
shown
right
bar
graph
fig
natur
cellular
set
ebov
gp
cleav
thermolysin
endosom
cathepsin
b
l
measur
fusion
without
prior
thermolysin
treatment
effector
cell
found
fusion
still
occur
albeit
smaller
extent
fig
bar
acidif
fig
bar
led
greater
amount
fusion
occur
neutral
ph
measur
reneutr
fig
bar
mock
transfect
effector
cell
without
thermolysin
treatment
support
dye
transfer
neutral
low
ph
verifi
fusion
requir
ebov
gp
eg
see
fig
observ
differ
extent
fusion
cell
treat
thermolysin
elimin
long
time
incub
reneutr
fig
ebov
gp
cleav
thermolysin
min
latenc
fusion
trigger
acidif
rais
temperatur
fig
dark
yellow
circl
occurr
fusion
latenc
thermolysin
cleav
protein
dark
red
squar
fusion
trigger
dark
yellow
circl
suggest
min
latenc
thermolysin
use
due
time
take
suffici
number
copi
cleav
gp
accumul
potenti
fusion
site
extent
fusion
nontreat
effector
cell
dark
yellow
circl
hr
reneutr
almost
equal
observ
hr
reneutr
thermolysintr
cell
hr
ph
puls
extent
fusion
independ
whether
ebov
gp
cleav
thermolysin
kinet
differ
larg
extent
like
due
min
latenc
fusion
occur
slope
linear
portion
rate
fusion
compar
suggest
latenc
kinet
fusion
low
neutral
ph
latenc
ebov
gpebov
gp
induct
cellcel
fusion
plo
pathogen
ebola
viru
ebov
outbreak
continu
occur
infect
die
current
approv
vaccin
antivir
therapeut
viru
ebov
initi
infect
fusion
within
endosom
experiment
endosom
interior
difficult
control
system
track
entri
sever
virus
cell
develop
employ
histor
method
reli
fusion
infecti
viru
pseudoviru
within
cell
cellcel
fusion
among
system
use
ebov
surpris
cellcel
fusion
system
develop
process
ebola
fusion
protein
gp
condit
necessari
fusion
elabor
year
ago
isol
report
ebov
gpmediat
cellcel
fusion
studi
follow
laboratori
includ
origin
cellcel
fusion
sever
import
advantag
intracellular
fusion
assay
includ
complet
control
aqueou
solut
bath
ectodomain
fusion
protein
present
studi
describ
direct
sensit
system
measur
ebov
gpmediat
cellcel
fusion
high
time
resolut
therebi
provid
fusion
kinet
system
exhibit
wellknown
central
properti
ebov
entri
provid
strong
support
util
cellcel
fusion
system
explor
mechan
ebov
entri
possibl
practic
whole
infecti
viru
ebov
gp
prototyp
class
viral
fusion
protein
synthes
homotrim
monom
cleav
subunit
proteas
within
golgi
apparatu
subunit
respons
bind
intracellular
receptor
niemann
pick
type
possibl
molecul
subunit
respons
membran
fusion
two
subunit
monom
remain
link
disulfid
bond
multitud
weak
interact
endocytosi
viru
subunit
cleav
endosom
proteas
cathepsin
b
andor
l
remain
attach
bind
low
ph
within
endosom
necessari
viral
fusion
known
whether
low
ph
directli
trigger
fusion
caus
conform
chang
gp
whether
augment
fusion
increas
activ
cathepsin
develop
system
discov
ebov
gpinduc
fusion
pore
connect
two
plasma
membran
readili
enlarg
time
contrast
pore
viral
fusion
protein
anomal
lack
growth
may
reason
cellcel
fusion
success
observ
mani
prior
attempt
use
less
sensit
assay
detect
fusion
question
low
ph
found
activ
cathepsin
acid
sole
caus
augment
fusion
ebov
gp
cell
surfac
artifici
cleav
thermolysin
presenc
cathepsin
inhibitor
extent
fusion
independ
ph
ebov
gp
mediat
cellcel
fusion
mediat
fusion
much
longer
viral
fusion
protein
iav
ha
compar
other
hiv
env
studi
thu
test
variou
time
whether
cell
pair
yet
fulli
fuse
hemifus
addit
mm
cpz
cell
pair
ruptur
hemifus
diaphragm
form
cell
pair
standard
mean
test
hemifus
use
thermolysintr
effector
cell
maxim
cleavag
ebov
gp
found
ad
cpz
either
min
reneutr
induc
dye
spread
alreadi
observ
strongli
indic
neglig
percentag
cell
hemifus
fuse
given
time
intracellular
receptor
ebov
gp
compar
extent
fusion
target
parent
hek
cell
versu
target
hek
cell
stabli
overexpress
effector
cell
treat
thermolysin
yield
fusion
ph
fig
bar
greater
extent
fusion
acid
ph
puls
fig
bar
extent
calcein
spread
greater
target
cell
overexpress
fig
bar
parent
cell
fig
bar
match
condit
fusion
still
phdepend
target
cell
overexpress
calcein
spread
greater
hr
ph
merg
viral
protein
express
transfect
effector
cell
shown
right
imag
cell
express
ebov
gp
treat
thermolysin
min
fusion
augment
ph
puls
cell
express
jsrv
env
ph
puls
use
trigger
fusion
effector
cell
express
influenza
viru
iav
ha
treat
trypsin
neuraminidas
describ
bound
hek
cell
fusion
trigger
ph
puls
mocktransfect
effector
cell
ph
puls
employ
fuse
cell
mark
arrowhead
set
experi
extent
fusion
hr
reneutr
ebov
gp
jsrv
env
iav
ha
thermolysin
treatment
result
greater
extent
fusion
cell
schemat
experiment
protocol
shown
bar
graph
e
effector
cell
target
cell
th
thermolysin
bar
graph
fusion
thermolysintr
effector
cell
express
ebov
gp
column
dark
red
greater
untreat
cell
column
dark
yellow
thermolysintr
nontreat
cell
ph
puls
appli
room
temperatur
augment
fusion
measur
addit
h
incub
neutral
ph
condit
least
experi
perform
typic
imag
use
obtain
data
bar
graph
shown
right
top
imag
cell
treat
thermolysin
bottom
imag
cell
treat
cell
fuse
mark
arrow
b
kinet
fusion
thermolysintr
dark
red
squar
untreat
dark
yellow
circl
effector
cell
cleav
ebov
gp
thermolysin
speed
fusion
kinet
extent
fusion
treat
untreat
cell
ph
puls
follow
h
reneutr
p
p
puls
fig
bar
absenc
puls
fig
bar
confirm
fusion
depend
presenc
gener
purifi
recombin
solubl
protein
consist
domain
c
fuse
gst
denot
puriti
size
confirm
fig
inset
ad
extern
solut
found
extent
fusion
increas
monoton
amount
ad
fig
accord
prior
demonstr
bind
ebov
gp
undergo
conform
chang
favor
fusion
augment
fusion
indic
although
suffici
amount
cell
surfac
stimul
fusion
amount
rel
small
fusion
consequ
limit
endosom
protein
small
fraction
may
present
plasma
membran
cell
assess
possibl
use
flow
cytometri
measur
overexpress
second
set
two
bar
led
greater
fusion
effector
cell
mocktransfect
target
cell
first
set
bar
experi
effector
cell
thermolysintr
ie
experi
reli
endogen
level
gp
cleavag
set
experi
ph
puls
label
puls
ph
led
fusion
ph
never
lower
condit
n
bind
antibodi
lifespan
bioscienc
parent
cell
shrna
target
stabli
express
one
set
cell
overexpress
anoth
set
fig
level
bind
secondari
fitclabel
antibodi
endogen
measur
mean
fluoresc
intens
mfi
greater
absenc
primari
ab
fig
bar
vs
bar
fig
express
reduc
cell
knock
shrna
bar
greater
cell
overexpress
bar
result
demonstr
copi
resid
plasma
membran
cell
use
target
cellcel
fusion
experi
ebov
gp
certainli
cleav
within
endosom
part
viral
infect
observ
cellcel
fusion
acid
ph
without
ad
thermolysin
extrem
like
fraction
gp
cell
surfac
cleav
fusioncompet
form
antibodi
recogn
cleav
gp
report
devis
altern
mean
quantit
measur
extent
cleavag
abl
distinguish
two
form
gp
use
properti
bind
cleav
uncleav
ebov
gp
use
examin
cleav
gp
flow
cytometri
parallel
measur
total
amount
gp
cell
surfac
use
antiflag
antibodi
bound
flag
tag
gp
construct
also
creat
gp
construct
intrins
like
cleav
cell
surfac
insert
furin
recognit
site
rrkr
amino
acid
refer
gp
furin
put
cleavag
site
catl
reason
exogen
express
furin
facilit
cleavag
insert
site
gener
fusionact
kda
subunit
extent
cleavag
gp
plasma
membran
well
extent
cellcel
fusion
would
greater
construct
wt
experiment
confirm
expect
determin
amount
cleav
gp
cell
surfac
ad
fuse
gst
cell
express
either
ebov
gp
gp
furin
measur
bind
antigst
antibodi
antibodi
detect
fitcconjug
secondari
antibodi
fig
fraction
wt
gp
cleav
parent
cell
fig
bar
cell
transfect
gp
furin
bar
specif
antibodi
bind
confirm
fold
higher
fluoresc
seen
cell
express
gp
bar
notabl
cotransfect
cell
gp
furin
furin
result
greater
cleavag
bar
vs
bar
found
express
total
wt
gp
measur
antiflag
antibodi
significantli
alter
coexpress
furin
fig
column
cell
coexpress
gp
furin
furin
consist
show
decreas
total
gp
compar
bar
possibl
due
nonspecif
degrad
gp
furin
determin
rel
percentag
cleav
gp
normal
cleav
gp
total
gp
rel
absolut
percentag
differ
antibodi
use
detect
cleav
vs
total
gp
found
higher
percentag
gp
plasma
membran
cleav
cell
coexpress
gp
furin
furin
cell
express
wt
gp
gp
furin
alon
fig
western
blot
analys
use
antiflag
antibodi
kind
gift
jame
cunningham
show
addit
furin
increas
amount
cleav
gp
furin
construct
compar
gp
furin
alon
fig
lane
left
right
panel
furin
cleav
wt
gp
lane
use
construct
verifi
increas
cleavag
ebov
gp
led
greater
extent
fusion
fig
cotransfect
cell
gp
furin
bar
led
extent
fusion
transfect
gp
alon
bar
contrast
cotransfect
gp
furin
furin
led
fusion
bar
transfect
gp
furin
bar
control
experi
transfect
furin
show
furin
per
se
promot
fusion
bar
experi
taken
togeth
establish
ebov
gp
appear
cell
surfac
cleav
gp
furin
construct
cleavag
augment
coexpress
furin
confirm
observ
fusion
inde
mediat
ebov
gp
util
mutat
previous
shown
greatli
reduc
viral
infect
use
mlv
pseudoviru
express
gp
observ
inde
level
infect
caus
point
mutant
fig
bar
doubl
mutant
point
mutant
bar
substanti
less
wt
gp
bar
measur
extent
cellcel
fusion
mediat
mutant
protein
extent
fusion
absenc
thermolysin
treatment
support
three
mutant
fig
bar
much
less
wt
gp
bar
flow
cytometri
measur
use
cell
fusion
experi
show
mutant
gp
well
express
cell
surfac
fig
experi
provid
support
reduc
infect
ebov
correl
reduc
gpmediat
fusion
next
test
small
molecul
inhibitor
prevent
ebov
entri
well
test
neutral
antibodi
ebov
gp
found
significantli
reduc
ebov
gpmediat
cellcel
fusion
fig
inhibitor
greatli
reduc
ebov
gpmediat
fusion
significantli
alter
cellcel
fusion
induc
either
semliki
forest
viru
sfv
iav
ha
fig
similarli
neutral
antibodi
recogn
interfac
reduc
ebov
gpmediat
fusion
iav
hainduc
fusion
anoth
central
fingerprint
gpmediat
fusion
inhibit
ebov
infect
bafilomycin
neutral
endosom
inhibit
infect
least
part
reduc
cathepsin
activ
turn
result
reduc
cleavag
found
addit
nm
reduc
amount
cleav
gp
appear
cell
surfac
fig
bar
vs
bar
occur
despit
consist
greater
amount
total
gp
plasma
membran
addit
fig
greater
amount
unexpect
possibl
prevent
lysosom
degrad
gp
normal
amount
cleav
gp
total
show
cleavag
cell
surfac
gp
significantli
reduc
fig
thu
data
support
conclus
aqueou
dye
spread
observ
due
fusion
induc
ebov
gp
mani
effect
ph
kinet
extent
ebov
gpinduc
fusion
found
unexpect
quit
differ
phdepend
fusion
viral
protein
notabl
extent
fusion
monoton
increas
ph
progress
lower
appar
ph
depend
qualit
vari
time
reneutr
fig
ph
puls
extent
fusion
alway
greater
achiev
acid
puls
follow
ph
puls
short
incub
time
ie
min
shift
neutral
ph
fusion
observ
less
acid
puls
fig
howev
ph
puls
reneutr
time
increas
extent
fusion
becam
effector
cell
label
dio
target
cell
dii
dye
excit
nm
laser
dio
emiss
detect
nm
dii
emiss
record
nm
fac
measur
trypsin
edta
ad
cell
prior
assay
treatment
separ
bound
cell
back
individu
cell
separ
fuse
cell
repres
data
lipid
dye
mix
shown
ph
puls
left
panel
ph
puls
right
panel
e
averag
percentag
fusion
determin
lipid
dye
mix
function
ph
bar
lipid
dye
spread
neglig
use
effector
cell
mocktransfect
bar
threshold
dio
dii
experi
indic
two
panel
fusion
score
percentag
fluoresc
particl
threshold
ie
third
quadrant
error
bar
sem
n
bar
extent
fusion
statist
compar
extent
ph
puls
p
p
less
depend
ph
fusion
independ
ph
h
reneutr
fig
contrast
effector
cell
express
iav
ha
show
typic
expect
respons
greater
extent
fusion
lower
ph
valu
time
reneutr
fusion
event
reach
full
extent
min
reneutr
fig
use
protocol
ebov
gp
experi
thu
iav
ha
induc
fusion
rapidli
ebov
gp
separ
experi
compar
extent
ebov
gpmediat
fusion
h
h
reneutr
follow
min
room
temperatur
acid
ph
puls
fig
h
reneutr
fusion
rel
independ
acid
ph
puls
low
ph
puls
greatli
augment
fusion
compar
fill
bar
open
bar
fig
equal
final
extent
fusion
ph
could
consequ
cell
pair
quickli
fuse
low
ph
therebi
elimin
possibl
fusion
although
consid
unlik
addit
singl
cell
measur
aqueou
dye
transfer
also
monitor
lipid
dye
continu
effector
cell
treat
thermolysin
target
cell
label
effector
cell
lipophil
fluoresc
dye
dio
label
target
cell
dii
determin
extent
fusion
flow
cytometri
fac
doubl
posit
cell
ie
third
quadrant
clearli
product
hemifus
cellcel
fusion
fig
effector
cell
treat
thermolysin
percentag
fusion
repres
experi
ph
optim
ph
fusion
fig
second
panel
ph
first
panel
averag
six
separ
experi
condit
reneutr
lipid
mix
greatest
ph
puls
less
ph
puls
cell
maintain
neutral
ph
fig
approxim
twofold
greater
fusion
determin
flow
cytometri
ph
also
agreement
data
spread
calcein
fig
mocktransfect
effector
cell
virtual
lipid
dye
spread
observ
effector
target
cell
fig
agreement
aqueou
dye
spread
measur
therefor
clear
ebov
gp
mediat
consider
amount
cellcel
fusion
optim
ph
calcein
movement
effector
target
cell
commenc
continu
ebov
gpmediat
fusion
extrem
slow
rate
gener
fluoresc
due
calcein
never
equal
target
effector
cell
ebov
gpinduc
fusion
fig
contrast
fusion
pore
creat
viral
fusion
protein
jsrv
env
fig
upper
imag
fluoresc
equal
possibl
ebov
gp
pore
eventu
close
prevent
calcein
attain
concentr
effector
target
cell
therefor
quantifi
rate
transfer
calcein
plot
calcein
fluoresc
effector
target
cell
function
time
fig
ebov
gpinduc
pore
red
curv
transfer
occur
time
cours
ten
minut
period
increas
fluoresc
target
cell
never
equal
decreas
fluoresc
effector
cell
fig
fluoresc
effector
target
cell
hand
equal
within
minut
jsrv
envmedi
pore
fig
blue
curv
exceedingli
slow
transfer
calcein
indic
ebov
gpmediat
pore
remain
extrem
small
fact
calcein
transfer
albeit
slowli
long
time
show
fusion
pore
irrevers
close
new
pore
open
within
ten
minut
format
control
ad
saponin
effector
cell
measur
releas
calcein
sure
dye
becom
compartment
therefor
fail
transfer
reason
unrel
size
fusion
pore
releas
fast
saponintr
cell
almost
complet
within
demonstr
overwhelm
major
calcein
fact
free
mobil
studi
size
rate
growth
ebov
gpmediat
fusion
pore
assess
size
dye
permeat
pore
time
load
effector
cell
cmtmr
addit
calcein
cmtmr
form
disulfid
bond
tripeptid
glutathion
complex
somewhat
larger
calcein
complex
glutathion
also
form
disulfid
bond
cytosol
protein
henc
cmtmr
fluoresc
label
protein
much
larger
calcein
consequ
size
distribut
molecul
label
cmtmr
expect
quit
divers
somewhat
larger
calcein
other
much
larger
found
cmtmr
transfer
cell
pair
calcein
exchang
occur
fig
rel
inabl
cmtmr
spread
indic
fusion
pore
typic
enlarg
suffici
allow
passag
molecul
size
nucleocapsid
ebov
actual
viral
infect
factor
absent
model
small
differ
fluoresc
effector
target
cell
connect
jsrv
env
pore
indic
small
percentag
calcein
free
transfer
possibl
bound
cellular
element
c
imag
effector
cell
load
calcein
green
cmtmr
red
target
cell
load
cmac
blue
taken
hr
reneutr
follow
ph
puls
calcein
transfer
white
arrow
left
panel
effector
cell
contact
target
cell
cmtmr
middl
panel
mix
cmac
one
cell
brown
arrow
overlay
calcein
cmtmr
shown
third
panel
calcein
white
arrow
cmtmr
brown
arrow
transfer
shown
system
probabl
promot
expans
fusion
pore
connect
envelop
endosom
membran
use
electr
capacit
measur
directli
quantit
assess
fusion
pore
size
slow
time
cours
ebov
gpmediat
fusion
necessit
tight
electr
seal
patch
pipett
plasma
membran
maintain
long
time
prove
difficult
practic
abl
howev
electr
observ
pore
cell
pair
three
case
case
pore
never
enlarg
within
format
gener
fluctuat
within
small
valu
conduct
fig
conduct
fluctuat
pore
return
baselin
show
pore
close
instead
remain
restrict
small
size
way
comparison
readili
seen
repres
trace
electr
measur
fusion
pore
creat
viral
protein
fig
fusion
pore
gener
significantli
enlarg
time
absenc
pore
enlarg
ebov
gp
suggest
mani
prior
attempt
monitor
cellcel
fusion
mediat
fusion
protein
succeed
report
molecul
need
permeat
fusion
pore
detect
fusion
larg
pass
pore
although
three
pore
electrophysiolog
measur
find
exhibit
increas
conduct
time
impli
slow
passag
fluoresc
dye
due
structur
prevent
access
pore
slow
pore
enlarg
could
due
number
factor
includ
slow
recruit
incorpor
addit
copi
cleav
gp
wall
pore
slow
accumul
lipid
wall
ad
nh
cl
extern
media
test
whether
acid
intracellular
compart
essenti
ebov
gpmediat
cellcel
fusion
addit
mm
nh
cl
greatli
reduc
fusion
ph
puls
absenc
thermolysin
treatment
avoid
activ
uncleav
ebov
gp
cell
surfac
fig
contrast
addit
mm
nh
cl
affect
fusion
induc
optim
ph
puls
either
sfv
iav
ha
fig
similarli
chloroquin
inhibit
cellcel
fusion
mediat
fusion
protein
ebov
protein
either
sfv
iav
fig
elimin
fusion
addit
mm
nh
cl
bar
condit
fig
like
caus
reduc
cathepsin
activ
neutral
intracellular
compart
larg
revers
ad
recombin
cathepsin
b
extern
solut
fig
bar
normal
acid
intracellular
compart
neutral
nh
cl
pool
ebov
gp
cell
surfac
previous
uncleav
must
cleav
ad
membraneimperm
recombin
proteas
doserespons
curv
inhibit
fusion
chloroquin
fig
nh
cl
fig
verifi
inhibit
fusion
increas
increas
concentr
neutral
agent
therefor
even
extern
solut
acidifi
ebov
gpmediat
cellcel
fusion
occur
unless
acid
intracellular
organel
maintain
conclud
ebov
gp
present
cell
surfac
requir
intracellular
compart
cleavag
consist
previou
report
possibl
howev
copi
cathepsin
plasma
membran
acidif
extern
solut
activ
cleav
ebov
gp
proteinas
k
pk
prove
use
assess
conform
chang
viral
protein
undergo
differ
stage
fusion
found
ebov
gp
pksensit
step
fusion
process
text
fig
fusion
restor
time
remov
pk
fig
normal
cellular
traffick
protein
led
replac
proteolyt
digest
gp
newli
deliv
intact
gp
fig
also
use
brefeldin
bfa
inhibitor
traffick
endoplasm
reticulum
golgito
character
consequ
fusion
alter
intracellular
traffick
ebov
gp
found
treatment
expect
increas
amount
cleav
ebov
gp
cell
surfac
led
greater
extent
fusion
text
fig
phdepend
cathepsin
activ
essenti
gpmediat
fusion
viru
intern
endosom
ebov
gp
believ
cleav
cathepsin
b
l
cathepsin
prevent
cathepsininduc
cleavag
treat
bound
effector
target
cell
cathepsin
b
inhibitor
cathepsin
l
inhibitor
zfycho
absenc
thermolysin
treatment
inhibitor
led
significantli
reduc
fusion
neutral
low
ph
fig
compar
untreat
treat
alway
chang
solut
contain
membraneimperm
buffer
use
control
ph
use
inhibitor
cathepsin
lactacystin
cathepsin
pepstatin
neither
thought
cleav
ebov
gpdid
lead
reduc
fusion
use
protocol
cathepsin
b
l
inhibit
experi
fig
result
provid
strong
support
fusion
observ
experi
absenc
thermolysin
treatment
due
least
part
copi
ebov
gp
cell
surfac
subunit
cleav
cathepsin
result
also
document
neither
cathepsin
cleav
ebov
fusioncompet
form
result
whole
clear
low
ph
induc
fusion
unless
subunit
cleav
known
cathepsin
activ
increas
acid
suggest
low
ph
act
least
part
augment
cathepsin
activ
cell
surfac
pattern
phdepend
fusion
observ
effector
cell
treat
thermolysin
cathepsin
activ
continu
inhibit
fusion
depend
ph
significantli
reduc
cathepsin
b
inhibitor
cathepsin
l
inhibitor
fig
thermolysintr
bar
set
column
rel
unaffect
cathepsin
inhibitor
bar
cellcel
fusion
exhibit
maximum
ph
column
compar
column
sever
cathepsin
exhibit
maxim
activ
ph
rang
maximum
extent
fusion
ph
would
like
due
ph
depend
cathepsin
activ
cell
surfac
control
experi
provid
addit
support
conclus
cathepsin
aid
ebov
gpmediat
fusion
cell
block
cathepsin
b
ad
cathepsin
b
inhibitor
immedi
applic
acid
ph
puls
result
substanti
effector
cell
thermolysintr
fusion
experi
perform
absenc
lowph
puls
first
set
column
ph
puls
second
set
column
cell
treat
thermolysin
cathepsin
inhibitor
ad
prior
thermolysin
treatment
maintain
throughout
experi
thermolysintr
cell
fusion
measur
case
without
third
set
bar
low
ph
puls
fourth
set
inhibitor
cathepsin
l
b
diminish
fusion
condit
four
cathepsin
inhibitor
ad
separ
time
mix
effector
target
cell
cathepsin
l
cathepsin
b
inhibitor
reduc
fusion
extent
ph
ph
cathepsin
b
inhibitor
without
effect
fusion
measur
hr
low
ph
puls
concentr
inhibitor
high
concentr
ensur
maxim
inhibit
b
contrast
experi
cathepsin
b
inhibitor
ad
subsequ
low
ph
puls
second
bar
less
fusion
occur
control
fill
bar
c
recombin
human
cathepsin
b
rh
catb
ad
effector
cell
treat
thermolysin
addit
rh
catb
hash
bar
led
substanti
increas
fusion
fill
bar
control
ph
puls
appli
promot
fusion
extent
fusion
measur
reneutr
experi
figur
error
bar
sem
cell
cotransfect
plasmid
encod
ebov
gp
cathepsin
b
cleav
gp
plasma
membran
measur
flow
cytometri
use
cleav
form
normal
total
gp
measur
antiflag
describ
fig
altern
gpexpress
cell
treat
thermolysin
cleav
gp
measur
normal
describ
p
p
reduct
extent
fusion
reneutr
fig
effector
cell
thermolysintr
reduct
control
reduct
also
occur
cathepsin
b
inhibitor
constantli
present
see
fig
nearli
equal
percentag
inhibit
fusion
expect
sinc
presenc
cathepsin
inhibitor
uncleav
copi
ebov
gp
would
cleav
period
reneutr
thu
low
ph
appear
promot
cleavag
ebov
gp
cathepsin
cell
surfac
incub
effector
cell
treat
thermolysin
recombin
human
cathepsin
b
rhcat
b
fig
bar
increas
fusion
significantli
control
bar
simplest
explan
increas
recombin
protein
led
higher
level
cleavag
induc
endogen
cellular
cathepsin
explicitli
test
whether
increas
activ
cathepsin
increas
likelihood
gp
cell
surfac
cleav
cotransfect
cell
express
gp
cathepsin
b
use
measur
percentag
gp
plasma
membran
cleav
describ
fig
percentag
greater
fig
column
control
column
presenc
cathepsin
b
transfect
use
techniqu
also
show
ad
thermolysin
solut
inde
increas
cleavag
cell
surfac
gp
fig
low
ph
directli
caus
conform
chang
ebov
gp
induc
fusion
work
via
increas
activ
cathepsin
abl
approach
question
use
abil
bfa
effect
block
deliveri
ebov
gp
cell
surfac
independ
use
cathepsin
inhibitor
prevent
gp
cleavag
incub
effector
cell
bfa
min
prevent
deliveri
ebov
gp
plasma
membran
prior
thermolysintreat
maintain
presenc
drug
solut
chang
extent
fusion
independ
ph
consider
less
traffick
inhibitor
employ
fig
clear
conclus
bfa
present
fusion
caus
copi
ebov
gp
cleav
thermolysin
remain
cell
surfac
find
ph
puls
affect
extent
fusion
show
acid
promot
conform
chang
cleav
ebov
gp
would
lead
fusion
inhibit
cathepsin
activ
test
conclus
cleav
ebov
gp
longer
requir
low
ph
induc
fusion
perform
experi
cathepsin
b
inhibitor
continu
present
fig
inhibitor
ad
isol
effector
cell
maintain
min
ensur
ebov
gp
deliv
plasma
membran
cleav
effector
cell
thermolysintr
alway
maintain
inhibitor
cell
bound
target
cell
extern
solut
acidifi
ph
reneutr
cell
maintain
h
manipul
perform
presenc
inhibitor
fig
experiment
protocol
illustr
top
extent
fusion
greater
inhibitor
ad
control
indic
deliveri
cell
surfac
ebov
gp
cleav
endosom
cathepsin
subsequ
thermolysin
treatment
significantli
contribut
fusion
importantlyand
central
mechan
ebov
gpmediat
fusionth
extent
fusion
independ
ph
find
strongli
impli
acid
condit
direct
effect
ebov
gpmediat
fusion
ph
depend
fusion
sole
due
abil
cathepsin
cleav
ebov
gp
cleav
acid
condit
directli
induc
conform
chang
cleav
ebov
gp
lead
fusion
use
cytoplasm
membran
dye
transfer
assay
establish
known
properti
ebov
fusion
occur
within
endosom
replic
cellcel
fusion
system
specif
inhibitor
ebov
infectionth
small
molecul
inhibitor
neutral
antibodi
fusion
inhibit
ebov
gpmediat
cellcel
fusion
iav
ha
sfv
fusion
lysosomotrop
agent
nh
cl
chloroquin
expect
ebov
gp
cleavag
elimin
cathepsin
activ
greatli
reduc
neutral
endosom
inhibit
cathepsin
activ
reduc
cleavag
ebov
gp
also
show
copi
resid
target
membran
gp
resid
plasma
membran
fraction
gp
properli
cleav
virtual
certain
cellcel
fusion
process
investig
present
studi
mediat
ebov
gp
like
past
lack
success
observ
cellcel
fusion
attribut
fact
fusion
pore
mediat
ebov
gp
cell
surfac
remain
small
time
scale
electr
measur
pore
enlarg
base
fluoresc
dye
spread
measur
enlarg
slowli
lesser
extent
pore
mediat
viral
fusion
protein
awar
may
even
tend
close
ebov
gp
fusion
pore
larg
enough
allow
passag
calcein
bare
littl
doubt
fluoresc
dye
cmtmr
permeat
pore
virtual
complex
protein
complex
becom
permeabl
pore
enlarg
electr
measur
directli
demonstr
ebov
gpinduc
pore
remain
small
cours
time
cellcel
fusion
experi
ebov
gpmediat
fusion
pore
significantli
enlarg
question
becom
readili
fusion
pore
enlarg
connect
ebov
envelop
endosom
membran
fusion
pore
must
expand
size
permit
passag
larg
viral
nucleocapsid
four
major
possibl
present
necessari
enlarg
extrem
slow
endosomevir
pore
ii
element
engag
plasma
endosom
membran
cytoskeleton
retard
growth
fusion
pore
iii
protein
twopor
calcium
channel
present
endosom
compart
support
ebov
fusion
requir
pore
enlarg
iv
control
calcium
concentr
eg
twopor
channel
regul
fusion
pore
format
enlarg
endosom
method
monitor
format
growth
fusion
pore
ebov
gpbear
viral
particl
within
endosom
need
answer
question
unambigu
shown
fraction
ebov
gp
cell
surfac
cleav
use
gp
furin
construct
also
demonstr
increas
cleavag
correl
greater
fusion
addit
function
evalu
cleavag
statu
ebov
gp
cell
surfac
ad
watersolubl
recombin
cathepsin
b
thermolysin
solut
found
proteas
promot
fusion
late
endosom
lysosom
gener
thought
cellular
site
cleavag
ebov
gp
cathepsin
like
fraction
ebov
gp
cleav
within
endosom
recycl
plasma
membran
mediat
cellcel
fusion
independ
ph
fig
suggest
uncleav
ebov
gp
reach
surfac
cleav
upon
acidif
extern
solut
cathepsin
within
plasma
membran
thermolysin
cleav
uncleav
copi
ebov
gp
deliv
cell
surfac
account
enhanc
fusion
addit
proteas
regardless
site
gp
cleavag
appreci
fraction
subunit
inde
cleav
fusioncompet
form
addit
thermolysin
serv
receptor
ebov
gp
endosom
essenti
viru
infect
cell
shown
confin
intracellular
membran
rather
copi
resid
plasma
membran
find
promot
ebov
gpmediat
cellcel
fusion
suggest
domain
c
alon
suffici
induc
need
conform
chang
fusion
protein
well
establish
extent
cellcel
fusion
correl
level
viral
fusion
protein
express
cell
surfac
thu
surpris
extent
cellcel
fusion
induc
ebov
gp
affect
deliveri
loss
plasma
membran
viral
fusion
protein
paramyxoviru
hendra
nipah
viru
f
protein
sar
coronaviru
protein
cellcel
fusion
sensit
protein
cycl
protein
requir
acid
intracellular
compart
cleavag
endosom
nipah
viru
endosom
transgolgi
network
hendra
viru
depend
cellcel
fusion
protein
traffick
unusu
typic
phdepend
viral
fusion
protein
protein
acid
promot
cleavag
instead
directli
induc
conform
chang
activ
typic
lowphdepend
fusion
protein
quickli
inactiv
promot
fusion
henc
protein
deliv
cell
surfac
subsequ
acid
puls
abl
promot
fusion
contrast
protein
induc
fusion
neutral
ph
promot
fusion
deliv
cell
surfac
result
show
ebov
gp
cleav
endosom
cathepsin
longer
sensit
ph
therefor
induc
fusion
arriv
plasma
membran
infect
subject
process
fusion
infect
need
alway
correl
extent
cellcel
fusion
exampl
recent
shown
activ
twopor
calcium
channel
endosom
requir
ebov
infect
ebov
infect
fuse
endosom
membran
contain
twopor
channel
tetrandrin
block
channel
inhibit
ebov
infect
found
tetrandrin
nm
affect
ebov
gpmediat
cellcel
fusion
notabl
extent
fusion
occur
h
neutral
ph
roughli
equal
extent
follow
ph
puls
fusion
induc
cleav
gp
phindepend
interpret
continu
increas
fusion
neutral
ph
time
consequ
intracellular
traffick
new
copi
ebov
gp
continu
replac
supplement
old
copi
newsuppl
cleav
copi
caus
fusion
cell
previous
fuse
thu
acidif
like
promot
fusion
earli
time
activ
surfac
cathepsin
cleav
ebov
gp
howev
present
clear
fusion
kinet
faster
ph
puls
ph
acid
puls
ph
depend
cathepsin
activ
complic
activ
gener
increas
acidif
cathepsin
exhibit
activ
rang
ph
lower
valu
ph
other
activ
maxim
intermedi
ph
also
ph
depend
cathepsin
activ
vari
environ
condit
redox
potenti
side
membran
cathepsin
resid
relev
cathepsin
eg
b
l
cell
surfac
optim
ph
cleav
ebov
gp
direct
test
whether
ebov
gp
cell
surfac
maxim
cleav
cathepsin
ph
requir
method
measur
percentag
ebov
gp
cleav
well
cathepsin
activ
cell
surfac
role
acid
ph
ebov
fusion
debat
field
data
unambigu
show
cellcel
fusion
regul
extracellular
ph
acid
extracellular
solut
principl
augment
activ
cathepsin
resid
plasma
membran
directli
promot
conform
chang
cleav
ebov
gp
cell
surfac
although
cathepsin
regard
endosom
membran
protein
copi
also
like
resid
plasma
membran
mani
endosom
deriv
great
reduct
fusion
caus
inhibit
cathepsin
activ
recoveri
fusion
addit
recombin
cathepsin
establish
cathepsin
activ
cell
surfac
consequenti
independ
experi
cathepsin
activ
inhibit
deliveri
protein
cell
surfac
block
show
phdepend
fusion
elimin
ebov
gp
cleav
demonstr
fusion
mediat
cleav
form
intrins
phindepend
cleav
ebov
gp
essenti
neutral
ph
fusioninduc
protein
experiment
observ
biolog
relev
phdepend
consequ
cathepsin
activ
faster
kinet
cellcel
fusion
ph
puls
puls
higher
valu
account
greater
cleavag
ebov
cell
surfac
ph
previou
studi
use
model
peptid
mimic
sixhelix
bundl
ebov
found
low
ph
increas
bundl
stabil
stage
fusion
bundl
format
occur
identifi
ebov
gp
may
exampl
bundl
form
subsequ
pore
format
occur
hiv
env
increas
bundl
stabil
aid
pore
enlarg
fusion
altern
model
peptid
may
mimic
bundl
stabil
within
full
length
structur
intact
gp
gener
rule
fusion
kinet
viral
protein
induc
fusion
neutral
ph
slower
protein
util
low
ph
trigger
could
explain
slow
fusion
kinet
ebov
gp
mediat
fusion
despit
classif
low
phrequir
process
altern
need
continu
deliv
ebov
gp
could
reason
ebov
gpmediat
cellcel
fusion
slow
develop
experiment
conveni
system
ebov
gpmediat
fusion
make
possibl
determin
molecular
mechan
ebov
releas
genom
infect
cell
result
conclus
diagrammat
summar
fig
intracellular
receptor
ebov
gp
within
endosom
shown
also
resid
plasma
membran
endosom
cathepsin
cleav
ebov
gp
cathepsin
resid
plasma
membran
also
cleav
surfac
gp
upon
acidif
extern
solut
cleav
uncleav
copi
ebov
gp
continu
deliv
retriev
surfac
henc
intracellular
traffick
contribut
extent
kinet
fusion
bind
ebov
gp
target
membran
inhibit
endocytot
retriev
consequ
ebov
gp
cleav
uncleav
accumul
potenti
fusion
site
lead
fusion
time
prevent
acidif
endosom
block
cleavag
ebov
gp
inhibit
deliveri
protein
cell
surfac
greatli
reduc
fusion
acidif
extern
solut
ph
increas
activ
cathepsin
resid
cell
surfac
result
addit
cleavag
ebov
gp
addit
thermolysin
convert
surfac
gp
cleav
form
therebi
result
maxim
extent
fusion
cellcel
fusion
induc
cleav
ebov
gp
depend
ph
provid
critic
insight
mechan
ebov
entri
infect
work
mainli
use
ntermin
flagtag
mucindelet
ebov
gp
construct
replac
signal
peptid
gp
preprotrypsin
follow
flag
sequenc
gp
mutant
includ
gp
furin
made
overlap
pcr
use
flagtag
gp
construct
templat
plasmid
express
jsrv
env
describ
express
iav
ha
dye
spread
experi
use
strain
plasmid
provid
judith
white
univers
virginia
charlottesvil
va
standard
calcium
phosphat
method
use
express
sfv
via
transfect
vector
plasmid
provid
margaret
kielian
albert
einstein
colleg
medicin
bronx
ny
small
molecular
inhibitor
gift
jame
cunningham
harvard
medic
school
boston
hek
cell
employ
previous
describ
hek
cell
stabli
express
gener
transduc
cell
pbabe
retrovir
vector
express
gift
kartik
chandran
follow
puromycin
select
sigma
cell
grown
dulbecco
modifi
eagl
dmem
medium
supplement
penicillinstreptomycin
plu
fetal
bovin
serum
fb
schemat
diagram
illustr
control
fusion
cleavag
ebov
gp
transport
cell
surfac
ebov
gp
synthes
er
transport
golgi
complex
process
subunit
ultim
target
plasma
membran
ebov
gp
undergo
endocytosi
plasma
membran
eventu
reach
late
endosom
lysosom
cleav
cellular
cathepsin
bound
recycl
back
plasma
membran
altern
ebov
gp
directli
cleav
cathepsin
plasma
membran
thermolysin
treatment
ebov
gp
protein
perman
remain
surfac
rather
undergo
continu
deliveri
remov
cleav
gp
accumul
potenti
fusion
site
lead
observ
increas
fusion
time
solid
arrow
denot
pathway
definit
establish
present
studi
dash
arrow
denot
pathway
like
occur
base
data
present
studi
light
dash
arrow
denot
pathway
suggest
data
present
studi
experi
use
ebov
gp
cell
maintain
eagl
medium
glucos
lglutamin
sodium
pyruv
supplement
cosmic
calf
serum
hyclon
logan
utah
pen
strep
gibco
mgml
sulfat
cell
gro
manassa
va
transfect
express
ebov
gp
standard
calcium
phosphat
procedur
cell
load
calceinam
previous
describ
sometim
coload
benzoyl
amino
tetramethylrhodamin
cmtmr
effector
cell
thermolysintr
cleav
ebov
gp
thermolysin
incub
cell
min
room
temperatur
exchang
solut
dmem
remov
thermolysin
residu
thermolysin
remov
spin
cell
three
time
replac
aqueou
solut
hek
cell
maintain
media
way
cell
use
cell
load
cmac
effector
cell
mix
includ
gentl
vortexin
tube
contain
either
pb
sometim
supplement
mgml
bsa
dmemwith
label
target
hek
cell
cell
ad
polylysineco
mgml
well
slide
thermo
fisher
allow
settl
adher
bottom
min
room
temperatur
ph
lower
min
room
temperatur
indic
valu
ph
unless
state
otherwis
use
exchang
solut
consist
mm
nacl
mm
kcl
mm
mgcl
mm
cacl
mm
me
solut
reneutr
ph
exchang
solut
temperatur
rais
reneutr
indic
time
gener
h
fusion
score
function
time
transfer
calcein
target
cell
describ
fusion
experi
util
iva
ha
control
express
ha
effector
cell
cleav
subunit
trypsin
previous
describ
label
effector
cell
cellsml
incub
dio
min
day
experi
target
cell
split
plate
glass
cover
slip
place
cultur
dish
allow
conveni
transfer
target
cell
label
dii
min
label
effector
cell
thermolysin
treat
ad
label
target
cell
bind
allow
occur
min
room
temperatur
wash
unbound
effector
cell
solut
bath
cover
slip
one
cover
slip
per
cultur
dish
acidifi
indic
ph
min
room
temperatur
cultur
dish
place
incub
h
cell
detach
cover
slip
ad
trypsin
divalentfre
solut
contain
mm
edta
min
room
temperatur
follow
vigor
repeat
pipet
dissoci
bound
ie
neither
hemifus
fuse
cell
coloc
two
lipid
dye
monitor
flow
cytometri
guava
easi
cite
guava
technolog
millipor
use
two
channel
emiss
one
dye
nm
dio
nm
dii
excit
nm
laser
protocol
follow
mocktransfect
cell
data
subtract
data
obtain
cell
express
ebov
gp
obtain
percentag
fuse
cell
domain
c
clone
vector
gst
tag
nterminu
ge
healthcar
life
scienc
pittsburgh
pa
express
fusion
protein
induc
e
coli
iptg
mm
purifi
glutathion
sepharos
ge
healthcar
life
scienc
protein
quantifi
bradford
assay
use
cellcel
fusion
measur
cleav
gp
express
cell
surfac
determin
use
nterminu
aa
lifespan
bioscienc
determin
ebov
gp
cleavag
cell
transfect
ebov
gp
gp
furin
presenc
absenc
plasmid
encod
furin
kind
gift
paul
bate
univers
pennsylvania
transfect
cell
detach
pb
contain
mm
edta
one
portion
million
cell
use
measur
cleav
gp
incub
cell
h
ice
follow
ad
mous
monoclon
antigst
antibodi
fluoresc
signal
quantifi
ad
fitcconjug
secondari
antimous
antibodi
use
flow
cytometri
anoth
portion
transfect
cell
also
million
use
measur
total
gp
express
cell
surfac
use
antiflag
antibodi
total
gp
determin
mean
fluoresc
intens
mfi
use
determin
percentag
gp
plasma
membran
cleav
amount
cleav
normal
total
gp
cleavag
gp
furin
cell
lysat
determin
western
blot
use
antiflag
antibodi
product
mlv
retrovir
pseudotyp
bear
ebov
gp
viral
infect
describ
previous
briefli
gplapsn
packag
cell
stabli
express
mlv
gagpol
alkalin
phosphatas
ap
transfect
plasmid
encod
ebov
gp
mutant
virus
produc
use
infect
htx
cell
subclon
viral
infect
determin
count
ap
foci
h
infect
proteolyt
determin
stage
fusion
ebov
gp
proteinas
ksensit
treat
cell
mgml
proteinas
k
min
maintain
remov
indic
variou
point
protocol
fig
cleav
ebov
gp
thermolysin
use
standard
protocol
ph
puls
incub
cell
h
ph
measur
fusion
experi
perform
parallel
day
control
proteinas
k
employ
extent
fusion
measur
brefeldin
use
inhibit
anterograd
protein
traffick
describ
experi
fig
determin
latenc
lower
ph
fusion
use
cell
mix
within
tube
place
polylysin
coat
cover
slip
within
cultur
dish
maintain
allow
settl
min
ph
lower
indic
valu
min
room
temperatur
exchang
solut
cover
slip
transfer
dish
neutral
ph
indic
time
time
transfer
defin
time
thermolysintr
cell
effector
cell
treat
prior
bind
target
cell
extent
fusion
quantifi
vari
time
spread
calcein
use
rate
accumul
calcein
target
cell
deplet
effector
cell
access
size
fusion
pore
function
time
fluoresc
effector
target
cell
proport
calcein
concentr
verifi
procedur
detail
neutral
intracellular
compart
nh
cl
mm
unless
otherwis
note
ad
bath
solut
maintain
throughout
cours
experi
includ
low
ph
puls
obtain
neutral
procedur
use
chloroquin
unless
state
otherwis
nm
caus
endosom
neutral
ionic
buffer
content
nh
clcontain
low
ph
solut
preadjust
requir
ph
maintain
osmot
strength
mosm
low
ph
puls
monitor
ebov
gp
express
recoveri
proteinas
k
treatment
cell
treat
mgml
proteas
min
room
temperatur
stain
protocol
describ
use
immedi
cell
maintain
h
dmem
indic
ebov
gpexpress
cell
transfer
ml
tube
incub
h
room
temperatur
primari
antibodi
human
antiebov
stock
mgml
ibt
bioservic
gaithersburg
md
dilut
pb
supplement
fetal
bovin
serum
three
wash
fbspb
solut
secondari
fitcconjug
goat
antihuman
antibodi
fisher
scientif
ad
final
concentr
maintain
min
room
temperatur
dark
cell
wash
twice
ad
slide
treat
polyllysin
mw
sigma
aldrich
st
loui
mo
cell
fix
min
room
temperatur
paraformaldehyd
wash
twice
dmem
pore
size
time
also
quantifi
use
patch
clamp
timeresolv
admitt
measur
often
refer
capacit
measur
fusion
promot
ph
puls
room
temperatur
fusion
pore
took
consider
time
form
seal
patch
pipett
cell
could
maintain
solut
temperatur
establish
temperatur
rais
min
attempt
electr
measur
procedur
reduc
time
establish
seal
fusion
pore
format
cover
slip
place
temperaturecontrol
chamber
microscop
stage
seal
establish
extern
solut
consist
mm
nmethylglucamin
mm
mgcl
mm
hepe
ph
solut
within
patch
pipett
mm
cesium
mm
mgcl
mm
bapta
oaminophenoxi
ethanen
n
n
n
tetraacet
mm
hepe
ph
electr
character
fusion
pore
creat
iav
ha
aslv
env
hiv
env
use
cell
line
stabli
express
fusion
protein
target
cell
stabli
express
cognat
receptor
cell
express
iav
ha
effector
cell
target
nih
enva
cell
express
aslv
env
tva
cell
target
cell
express
hiv
env
hela
cell
target
pairwis
student
ttest
use
compar
outcom
manipul
fusion
compar
control
figur
unless
otherwis
indic
singl
asterisk
denot
p
two
asterisk
denot
p
three
asterisk
denot
p
period
proteinas
k
pk
present
mark
schemat
protocol
number
correspond
bar
number
regardless
whether
pk
present
prior
bar
subsequ
bar
treat
effector
cell
thermolysin
presenc
pk
virtual
elimin
fusion
similarli
ad
maintain
pk
effector
cell
bound
target
cell
led
greatli
reduc
fusion
bar
ad
pk
immedi
low
ph
puls
bar
hardli
affect
fusion
b
ebov
gpmediat
fusion
recov
time
proteinas
k
treatment
lefthand
bar
pair
denot
ph
puls
appli
ph
puls
appli
right
hand
bar
ad
proteinas
k
wash
immedi
prior
thermolysin
treatment
virtual
abolish
fusion
first
set
two
bar
allow
hr
proteinas
k
remov
thermolysin
treatment
restor
fusion
second
set
bar
wait
h
complet
restor
fusion
third
set
bar
effect
pk
treatment
ebov
gp
express
assess
use
voloc
imag
softwar
perkin
elmer
integr
fluoresc
per
field
imag
field
per
datum
point
calcul
subtract
fluoresc
background
determin
mocktransfect
imag
quantif
show
express
ebov
gp
greatli
reduc
proteinas
k
treatment
significantli
recov
proteas
absent
h
demonstr
ebov
gp
express
level
steadi
time
tif
fig
inhibitor
traffick
show
ebov
gp
dynam
exchang
plasma
intracellular
membran
presenc
brefeldin
bfa
point
fusion
protocol
util
thermolysintr
effector
cell
ph
puls
reduc
fusion
greatli
bar
compar
control
bar
bfa
includ
wash
bfa
immedi
treat
effector
cell
thermolysin
led
greater
fusion
bar
wait
min
washout
thermolysin
treatment
led
fusion
bar
compar
control
ad
maintain
bfa
bind
effector
target
cell
appli
low
ph
puls
led
substanti
reduc
fusion
bar
appli
bfa
low
ph
puls
led
less
fusion
control
bar
greater
fusion
drug
ad
prior
low
ph
puls
bar
extent
fusion
higher
bar
thermolysin
use
cleav
ebov
gp
prior
measur
fusion
condit
allow
meaning
comparison
tif
